These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

447 related items for PubMed ID: 11095341

  • 1. Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis.
    Saarinen S, Olerup O, Broomé U.
    Am J Gastroenterol; 2000 Nov; 95(11):3195-9. PubMed ID: 11095341
    [Abstract] [Full Text] [Related]

  • 2. What is the association of primary sclerosing cholangitis with sex and inflammatory bowel disease in Turkish patients?
    Bayraktar Y, Arslan S, Saglam F, Uzunalimoglu B, Kayhan B.
    Hepatogastroenterology; 1998 Nov; 45(24):2064-72. PubMed ID: 9951867
    [Abstract] [Full Text] [Related]

  • 3. Immune-mediated diseases in primary sclerosing cholangitis.
    Lamberts LE, Janse M, Haagsma EB, van den Berg AP, Weersma RK.
    Dig Liver Dis; 2011 Oct; 43(10):802-6. PubMed ID: 21700515
    [Abstract] [Full Text] [Related]

  • 4. Increased prevalence of primary sclerosing cholangitis among first-degree relatives.
    Bergquist A, Lindberg G, Saarinen S, Broomé U.
    J Hepatol; 2005 Feb; 42(2):252-6. PubMed ID: 15664252
    [Abstract] [Full Text] [Related]

  • 5. Autoantibodies to glutathione S-transferase theta 1 in patients with primary sclerosing cholangitis and other autoimmune diseases.
    Ardesjö B, Hansson CM, Bruder CE, Rorsman F, Betterle C, Dumanski JP, Kämpe O, Ekwall O.
    J Autoimmun; 2008 Jun; 30(4):273-82. PubMed ID: 18242955
    [Abstract] [Full Text] [Related]

  • 6. Surgical outcome in patients with primary sclerosing cholangitis undergoing ileal pouch-anal anastomosis: a case-control study.
    Gorgun E, Remzi FH, Manilich E, Preen M, Shen B, Fazio VW.
    Surgery; 2005 Oct; 138(4):631-7; discussion 637-9. PubMed ID: 16269291
    [Abstract] [Full Text] [Related]

  • 7. Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis.
    Karlsen TH, Hampe J, Wiencke K, Schrumpf E, Thorsby E, Lie BA, Broomé U, Schreiber S, Boberg KM.
    Am J Gastroenterol; 2007 Jan; 102(1):115-21. PubMed ID: 17100974
    [Abstract] [Full Text] [Related]

  • 8. Fatigue in patients with primary sclerosing cholangitis.
    Björnsson E, Simren M, Olsson R, Chapman RW.
    Scand J Gastroenterol; 2004 Oct; 39(10):961-8. PubMed ID: 15513335
    [Abstract] [Full Text] [Related]

  • 9. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study.
    Bergquist A, Glaumann H, Persson B, Broomé U.
    Hepatology; 1998 Feb; 27(2):311-6. PubMed ID: 9462625
    [Abstract] [Full Text] [Related]

  • 10. Primary sclerosing cholangitis is associated with extended HLA-DR3 and HLA-DR6 haplotypes.
    Wiencke K, Karlsen TH, Boberg KM, Thorsby E, Schrumpf E, Lie BA, Spurkland A.
    Tissue Antigens; 2007 Feb; 69(2):161-9. PubMed ID: 17257319
    [Abstract] [Full Text] [Related]

  • 11. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
    Vera A, Gunson BK, Ussatoff V, Nightingale P, Candinas D, Radley S, Mayer A, Buckels JA, McMaster P, Neuberger J, Mirza DF.
    Transplantation; 2003 Jun 27; 75(12):1983-8. PubMed ID: 12829898
    [Abstract] [Full Text] [Related]

  • 12. Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.
    Maggiore G, Riva S, Sciveres M.
    Minerva Gastroenterol Dietol; 2009 Mar 27; 55(1):53-70. PubMed ID: 19212308
    [Abstract] [Full Text] [Related]

  • 13. Relationship of inflammatory bowel disease and primary sclerosing cholangitis.
    Fausa O, Schrumpf E, Elgjo K.
    Semin Liver Dis; 1991 Feb 27; 11(1):31-9. PubMed ID: 2047887
    [Abstract] [Full Text] [Related]

  • 14. Non-IBD immunological diseases are a risk factor for reduced survival in PSC.
    Rupp C, Mummelthei A, Sauer P, Weiss KH, Schirmacher P, Stiehl A, Stremmel W, Gotthardt DN.
    Liver Int; 2013 Jan 27; 33(1):86-93. PubMed ID: 23157607
    [Abstract] [Full Text] [Related]

  • 15. Susceptibility to primary sclerosing cholangitis is associated with polymorphisms of intercellular adhesion molecule-1.
    Yang X, Cullen SN, Li JH, Chapman RW, Jewell DP.
    J Hepatol; 2004 Mar 27; 40(3):375-9. PubMed ID: 15123348
    [Abstract] [Full Text] [Related]

  • 16. Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer.
    Broomé U, Bergquist A.
    Semin Liver Dis; 2006 Feb 27; 26(1):31-41. PubMed ID: 16496231
    [Abstract] [Full Text] [Related]

  • 17. Hepatobiliary disease in inflammatory bowel disease.
    Balan V, LaRusso NF.
    Gastroenterol Clin North Am; 1995 Sep 27; 24(3):647-69. PubMed ID: 8809241
    [Abstract] [Full Text] [Related]

  • 18. Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis.
    Bergquist A, Montgomery SM, Bahmanyar S, Olsson R, Danielsson A, Lindgren S, Prytz H, Hultcrantz R, Lööf LA, Sandberg-Gertzén H, Almer S, Askling J, Ehlin A, Ekbom A.
    Clin Gastroenterol Hepatol; 2008 Aug 27; 6(8):939-43. PubMed ID: 18674735
    [Abstract] [Full Text] [Related]

  • 19. Primary sclerosing cholangitis is associated to an extended B8-DR3 haplotype including particular MICA and MICB alleles.
    Wiencke K, Spurkland A, Schrumpf E, Boberg KM.
    Hepatology; 2001 Oct 27; 34(4 Pt 1):625-30. PubMed ID: 11584356
    [Abstract] [Full Text] [Related]

  • 20. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S, Andersen SN, Aamodt G, Langmark F, Clausen OP, Aadland E, Fausa O, Rydning A, Vatn MH.
    Scand J Gastroenterol; 2009 Oct 27; 44(1):46-55. PubMed ID: 18609187
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.